Literature DB >> 6142902

Effects of glucagon on plasma amino acids.

G Boden, I Rezvani, O E Owen.   

Abstract

The effects of glucagon deficiency and excess on plasma concentrations of 21 amino acids were studied in six normal human subjects for 8 h. During glucagon deficiency, produced by intravenous infusion of somatostatin (0.5 mg/h) and insulin (5 mU/kg per h), amino acid concentration (sum of 21 amino acids) rose from 2,607 +/- 76 to 2,922 +/- 133 microM after 4 h (P less than 0.025). The largest increases occurred in lysine (+26%), glycine (+24%), alanine (+23%), and arginine (+23%) concentrations. During glucagon excess produced by intravenous infusion of somatostatin (0.5 mg/h), insulin (5 mU/kg per h), and glucagon (60 ng/kg per h), amino acid concentration decreased from 2,774 +/- 166 to 2,388 +/- 102 microM at 8 h (P less than 0.01). The largest decreases occurred in citrulline (-37%), proline (-32%), ornithine (-30%), tyrosine (-23%), glycine (-20%), threonine (-21%), and alanine (18%) concentrations. Urinary urea nitrogen and total nitrogen excretions were lower during glucagon deficiency than during glucagon excess (3.1 +/- 0.2 vs. 6.3 +/- 2.3 g/8 h, P less than 0.05 and 4.8 +/- 1.0 vs 7.0 +/- 2.6 g/8 h, respectively, P less than 0.05). Biostator-controlled euglycemic glucagon deficiency was produced in four normal subjects for 4 h to eliminate possible effects of changes in glucose concentration on amino acids. Amino acid concentration (sum of 18 amino acids) increases occurred in arginine (+42%), alanine (+28%), glutamine (+25%), and glycine (+16%) concentrations. The data show that small changes (-66 pg/ml and +50 pg/ml) in basal glucagon concentrations cause plasma amino acid concentrations to change in opposite directions. The finding that urinary excretion of nitrogen and urea nitrogen was greater during glucagon excess than during glucagon deficiency suggested alterations in the rate of gluconeogenesis from amino acids as one mechanism by which glucagon controls blood amino acid levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142902      PMCID: PMC425081          DOI: 10.1172/JCI111272

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Effect of insulin on glucagon enhanced lipolysis in vitro.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1969-06       Impact factor: 10.122

2.  Amino acid metabolism during prolonged starvation.

Authors:  P Felig; O E Owen; J Wahren; G F Cahill
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

3.  Elevation of plasma glutamate in gout. Its possible role in the pathogenesis of hyperuricemia.

Authors:  A S Pagliara; A D Goodman
Journal:  N Engl J Med       Date:  1969-10-02       Impact factor: 91.245

4.  Critical variables in the radioimmunoassay of serum insulin using the double antibody technic.

Authors:  J S Soeldner; D Slone
Journal:  Diabetes       Date:  1965-12       Impact factor: 9.461

5.  [A new determination of the neutral fats in blood serum and tissue. II. Reliability of the method, other neutral fat determinations, normal values for triglycerides and glycerin in human blood].

Authors:  M Eggstein
Journal:  Klin Wochenschr       Date:  1966-03-01

6.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

7.  Photometric "titration" of free fatty acids with the Technicon AutoAnalyzer.

Authors:  E Lorch; K F Gey
Journal:  Anal Biochem       Date:  1966-08       Impact factor: 3.365

8.  Hormone-fuel interrelationships during fasting.

Authors:  G F Cahill; M G Herrera; A P Morgan; J S Soeldner; J Steinke; P L Levy; G A Reichard; D M Kipnis
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

9.  Glucagon levels and metabolic effects in fasting man.

Authors:  E B Marliss; T T Aoki; R H Unger; J S Soeldner; G F Cahill
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Amino acid metabolism in exercising man.

Authors:  P Felig; J Wahren
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  24 in total

1.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.

Authors:  S Del Prato; S Vigili de Kreutzenberg; R Trevisan; E Duner; A Avogaro; R Nosadini; U Baccaglini; C Tremolada; A Tiengo
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

3.  Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.

Authors:  Nicolai J Wewer Albrechtsen; Kristine Færch; Troels M Jensen; Daniel R Witte; Jens Pedersen; Yuvaraj Mahendran; Anna E Jonsson; Katrine D Galsgaard; Marie Winther-Sørensen; Signe S Torekov; Torsten Lauritzen; Oluf Pedersen; Filip K Knop; Torben Hansen; Marit E Jørgensen; Dorte Vistisen; Jens J Holst
Journal:  Diabetologia       Date:  2018-01-05       Impact factor: 10.122

4.  Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.

Authors:  Jinrang Kim; Haruka Okamoto; ZhiJiang Huang; Guillermo Anguiano; Shiuhwei Chen; Qing Liu; Katie Cavino; Yurong Xin; Erqian Na; Rachid Hamid; Joseph Lee; Brian Zambrowicz; Roger Unger; Andrew J Murphy; Yan Xu; George D Yancopoulos; Wen-Hong Li; Jesper Gromada
Journal:  Cell Metab       Date:  2017-06-06       Impact factor: 27.287

5.  Increased amino acid clearance and urea synthesis in a patient with glucagonoma.

Authors:  T P Almdal; H Heindorff; L Bardram; H Vilstrup
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

6.  Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.

Authors:  Katrine D Galsgaard; Marie Winther-Sørensen; Cathrine Ørskov; Hannelouise Kissow; Steen S Poulsen; Hendrik Vilstrup; Cornelia Prehn; Jerzy Adamski; Sara L Jepsen; Bolette Hartmann; Jenna Hunt; Maureen J Charron; Jens Pedersen; Nicolai J Wewer Albrechtsen; Jens J Holst
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

7.  Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.

Authors:  Young Lee; May-Yun Wang; Xiu Quan Du; Maureen J Charron; Roger H Unger
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

8.  Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides.

Authors:  Chika Watanabe; Yusuke Seino; Hiroki Miyahira; Michiyo Yamamoto; Ayako Fukami; Nobuaki Ozaki; Yoshiko Takagishi; Jun Sato; Tsutomu Fukuwatari; Katsumi Shibata; Yutaka Oiso; Yoshiharu Murata; Yoshitaka Hayashi
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

9.  Circulating biomarkers of nitric oxide bioactivity and impaired muscle vasoreactivity to exercise in adults with uncomplicated type 1 diabetes.

Authors:  Elodie Lespagnol; Sémah Tagougui; Bernadette O Fernandez; Farid Zerimech; Régis Matran; Patrice Maboudou; Serge Berthoin; Amandine Descat; Isabelle Kim; Mehdi Pawlak-Chaouch; Julien Boissière; Eric Boulanger; Martin Feelisch; Pierre Fontaine; Elsa Heyman
Journal:  Diabetologia       Date:  2020-11-21       Impact factor: 10.122

Review 10.  Integrating the inputs that shape pancreatic islet hormone release.

Authors:  Glyn M Noguchi; Mark O Huising
Journal:  Nat Metab       Date:  2019-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.